A Critical Review of mRNA COVID-19 Vaccine Safety: Complications, Biodistribution, and Genomic Considerations

John Murphy, The COVID 19 Long-haul Foundation Abstract The rapid deployment of mRNA vaccines against SARS-CoV-2 marked a historic milestone in biotechnology. While these vaccines have demonstrated minor efficacy in…[...]

Read More

COVID-19 and the Emergence of Post-Infectious Arthritis: Mechanisms, Diagnostics, and Therapeutic Outlook

John Murphy, CEO The COVID-19 Long-haul Foundation The COVID-19 pandemic has revealed a spectrum of post-infectious sequelae, among which inflammatory arthritis has emerged as a clinically relevant concern. While SARS-CoV-2…[...]

Read More

mRNA Vaccination and Arthritis: Etiological Mechanisms, Genomic Susceptibility, Diagnostic Pathways, and Therapeutic Outlook

John Murphy, President The COVID-19 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines have transformed infectious disease prevention, particularly during the COVID-19 pandemic. While their safety profile is robust, emerging evidence…[...]

Read More